期刊文献+

替米沙坦联合氨氯地平与氨氯地平单药治疗原发性高血压病的疗效及安全性比较 被引量:7

Comparison of curative effect and safety between telmisartan combined with amlodipine and single amlodipine in the treatment of primary hypertension
下载PDF
导出
摘要 目的探讨替米沙坦联合氨氯地平与氨氯地平单药治疗原发性高血压病的疗效及安全性。方法 80例原发性高血压病患者,随机分为试验组与对照组,各40例。对照组采取氨氯地平治疗,试验组采用替米沙坦联合氨氯地平,比较两组日间平均收缩压(d SBP)、舒张压(d DBP),夜间平均收缩压(n SBP)、舒张压(n DBP)以及安全性。结果治疗后试验组各指标均优于对照组(P<0.05)。结论采取替米沙坦联合氨氯地平治疗原发性高血压病,可以有效降低患者的平均血压,并且两药合用副作用少,值得在临床推广。 Objective To investigate curative effect and safety of telmisartan combined with amlodipine and single amlodipine in the treatment of primary hypertension. Methods A total of 80 patients with primary hypertension were randomly divided into experimental group and control group, with 40 cases in each group. The control group received amlodipine for treatment, and the experimental group received telmisartan combined with amlodipine. Comparison was made on day mean systolic blood pressure(d SBP), day mean diastolic blood pressure(d DBP), night mean systolic blood pressure(n SBP), night mean diastolic blood pressure(n DBP) and safety between the two groups. Results The experimental group had all better indexes than the control group after treatment(P0.05). Conclusion Combination of telmisartan and amlodipine can effectively reduce mean blood pressure in treating primary hypertension, along with few side effects. It is worth clinical promotion.
出处 《中国现代药物应用》 2016年第8期19-20,共2页 Chinese Journal of Modern Drug Application
关键词 替米沙坦 氨氯地平 原发性高血压病 Telmisartan Amlodipine Primary hypertension
  • 相关文献

二级参考文献28

  • 1覃天锦,王际军,阎婷.替米沙坦对老年高血压病患者脉压的影响[J].心血管康复医学杂志,2007,16(1):63-65. 被引量:14
  • 2孙宁玲,喜杨,荆珊,薛春光.左旋氨氯地平的时间药理学对纠正老年非杓型高血压的作用[J].中华高血压杂志,2007,15(1):26-29. 被引量:92
  • 3Kakuta H,Sudoh K,Sasamata M,et al.Telmisartan has the strongest binding affinity to angiotensin Ⅱ type 1 receptor:comparison with other angiotensin Ⅱ type 1 receptor blockers.Int J Clin Pharmacol Res,2005,25(1):412-461.
  • 4卫生部心血管病防治研究中心.中国心血管病报告2005.北京:中国大百科全书出版社,2006:1-2.
  • 5王文,马丽媛,张宇清,邓卿,刘明波,刘力生,代表CHIEF研究协作组.中国高血压综合干预研究方案——起始联合降压、适度调脂和生活方式综合干预的全国多中心随机对照试验[J].中国循证医学杂志,2007,7(11):810-815. 被引量:31
  • 6Salvi E,Kutalik Z,Glorioso N,et al.Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase[J].Hypertension,2012,59(2):248-255.
  • 7Karaman M,Balta S,Seyit Ahmet AY,et al.The comparative effects of valsartan and amlodipine on v Wf levels and N/L ratio in patients with newly diagnosed hypertension[J].Clin Exp Hypertens,2013,35(7):516-522.
  • 8Kojima M,Ohashi M,Dohi Y,et al.Titration of telmisartan,but not addition of amlodipine,reduces urine albumin in diabetic patients treated with telmisartandiuretic[J].J Hypertens,2013,31(1):186-191.
  • 9Kjeldsen SE,Messerli FH,Chiang CE,et al.Are fixed-dose combination antihypertensives suitable as first-line therapy?[J].Curr Med Res Opin,2012,28(10):1685-1697.
  • 10Ley L,Schumacher H.Telmisartan plus amlodipine singlepill combination for the management of hypertensive patients with a metabolic risk profile(added-risk patients)[J].Curr Med Res Opin,2013,29(1):41-53.

共引文献44

同被引文献47

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部